This week, 10 medical devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Winner Medical Group (WWIN) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
LeMaitre Vascular, Inc. (LMAT) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. LeMaitre Vascular manufactures medical devices for vascular surgeons and interventionists. For more information, get Portfolio Grader’s complete analysis of LMAT stock.
Neovasc Inc. (NVCN) shows solid improvement this week. The company’s rating rises from a B to an A. For more information, get Portfolio Grader’s complete analysis of NVCN stock.
ABIOMED, Inc. (ABMD) improves from a B to an A rating this week. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Hologic, Inc. (HOLX) is seeing ratings go up from a B last week to an A this week. Hologic develops, manufactures, and markets x-ray systems. For more information, get Portfolio Grader’s complete analysis of HOLX stock.
STERIS Corporation (STE) gets a higher grade this week, advancing from a B last week to an A. STERIS provides products and services related to infection prevention and surgical procedures. For more information, get Portfolio Grader’s complete analysis of STE stock.
Rockwell Medical, Inc.’s (RMTI) ratings are looking better this week, moving up to a B from last week’s C. Rockwell Medical manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. For more information, get Portfolio Grader’s complete analysis of RMTI stock.
This week, AngioDynamics, Inc.’s (ANGO) ratings are up from a C last week to a B. AngioDynamics is a developer and manufacturer of gastrointestinal contrast agents and related imaging accessories. For more information, get Portfolio Grader’s complete analysis of ANGO stock.
Abaxis, Inc. (ABAX) earns an A this week, jumping up from last week’s grade of B. Abaxis is engaged in the development, manufacture, marketing and sale of portable blood analysis systems for use in the human or veterinary patient-care setting. For more information, get Portfolio Grader’s complete analysis of ABAX stock.
Varian Medical Systems, Inc. (VAR) is seeing ratings go up from a C last week to a B this week. Varian Medical Systems manufactures and sells equipment and software products for treating cancer with radiotherapy and radiosurgery. For more information, get Portfolio Grader’s complete analysis of VAR stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
